The CARD14 gene helps skin cells control inflammation and support a healthy skin barrier. This gene plays an important role in how the skin responds to irritation and minor injury. When it does not work normally, especially if it becomes overactive, it can raise skin inflammation and contribute to conditions such as plaque psoriasis or pityriasis rubra pilaris. People may notice red, thick, scaly patches, while doctors may see ongoing inflammation in the skin.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the parts of cells that carry out much of the work. Others mainly guide when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can shape how you respond to food, stress, and medications. You can read more about this topic in the LearnHub.
Overview
CARD14Gene function
What if the gene works
The CARD14 gene helps skin cells pass along immune signals. This supports controlled inflammation and healthy skin renewal, especially after irritation or minor injury.
Risk
What if the gene does not work
Variants in the CARD14 gene can cause inflammatory skin conditions, most often psoriasis, including plaque and pustular forms, and sometimes pityriasis rubra pilaris. Effects can range from milder skin changes to earlier, more widespread, or more persistent disease.
Treatment
What does that mean for your treatment
No treatment or management approach is currently established specifically for pathogenic variants in the CARD14 gene. The CARD14 gene is being studied as a marker of overactive skin inflammation, and case reports suggest some people may respond to targeted psoriasis drugs, but this is not yet guideline based CARD14 care.
Conditions associated with CARD14
Gene function
What if the gene works
Much of the known CARD14 gene function in skin cells centers on how the outer layer of skin handles everyday signals. Its protein acts like a relay point inside keratinocytes, the main cells in the skin's surface. This helps skin cells coordinate normal immune messages and steady renewal.
Inside keratinocytes, the CARD14 gene passes signals from the cell surface to control centers inside the cell. This lets skin cells respond in an organized way to routine cues from their surroundings.
One of its main roles is to help switch on NF-κB (a cell signaling pathway that helps control immune activity). In normal skin, this supports measured release of chemical messages that coordinate local defense.
The CARD14 gene helps skin cells balance growth, maturation, and communication as the outer skin layer renews itself. This supports orderly turnover, so older cells are replaced while the skin barrier stays steady.
When skin faces everyday friction, dryness, or mild irritation, CARD14-related signaling helps cells adjust their response. By linking outside cues to internal messages, it supports stable function in the epidermis, the skin's protective outer layer.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. Variants like these are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body reacts to environmental influences. Many do not cause any noticeable effects and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many disease-linked variants in the CARD14 gene make its protein too active, so inflammation signals in skin cells stay switched on more than they should. This is how CARD14 gene variants affect skin inflammation: milder variants may increase signaling only slightly, while more disruptive variants can keep the pathway active longer or more strongly. Stronger activating variants are often linked to earlier onset or more extensive psoriasis or related inflammatory skin disease.
How variants are linked to conditions
Variants in the CARD14 gene are linked to several inflammatory skin conditions. Certain pathogenic variants can cause CARD14-associated papulosquamous eruption and can confirm a genetic form of pityriasis rubra pilaris, while other CARD14 changes are associated with a higher risk of plaque psoriasis and generalized pustular psoriasis. For risk-linked variants, these findings describe tendency, not certainty, so many carriers never develop symptoms.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology, and they are common across the general population. Most variants do not directly affect health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce risk related to the CARD14 gene. In families with a disease-causing CARD14 change, the variant itself is the main factor, while symptoms and severity can still vary from one person to another.
Inheritance of CARD14 variants
CARD14-related conditions are usually inherited in an autosomal dominant pattern. This means a person with a disease-causing variant in the CARD14 gene has a 50% chance of passing it on to each child, regardless of sex. In families asking how CARD14 gene variants are inherited, the key point is that one altered copy can be enough to cause the condition. A child can inherit the variant from an affected mother or father.
What does my CARD14 result mean for my family?
For well-established CARD14-related skin conditions, the pattern is usually dominant, which means close relatives such as a parent, child, brother, or sister may also carry the same change and may have psoriasis-like skin symptoms or a related rash. Family effects can vary a lot, even within the same family, so some relatives may have milder skin changes or no obvious symptoms. Because of that, a CARD14 result can be relevant for other family members as well.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CARD14 variants usually uses a blood or saliva sample. The lab reads the CARD14 gene's DNA sequence to check for a variant and compares any finding with established evidence. Results may be reported as pathogenic, benign, or uncertain.
When should I consider getting a genetic test?
Genetic testing for the CARD14 gene may be worth discussing if you or your child has psoriasis that starts early, is unusually severe, or runs in the family, especially pustular psoriasis. It can also help when doctors are trying to explain a rare inherited skin condition with thick, scaly, inflamed skin.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains varies by the condition and the specific type of variant. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug faster, while others process it more slowly or are more sensitive to its effects. This helps explain why the same treatment can work well for one person but less well for another, or cause more side effects. These differences are common and can influence both how well a medicine helps and how strongly your body reacts to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way medications work. By studying links between genes and drugs, it helps explain why the same treatment can have different effects in different people. For many medicines, genes influence both how the body handles a drug and how strong its effects are. This information can support more personalized, well informed treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the CARD14 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice, so general health concerns or questions about medicines are best discussed with your doctor. Seek medical advice if treatment is not helping, side effects are bothering you, or skin symptoms are getting worse.
History
CARD14 entered the genetics literature in the early 2000s, during a period when researchers were mapping many genes involved in immune signaling. Building on this early work, scientists uncovered more about the CARD14 gene when studies of families with inherited psoriasis and related skin conditions pointed to changes in this gene. Around 2012, those reports helped connect CARD14 to forms of pustular psoriasis and pityriasis rubra pilaris, giving clinicians a clearer genetic explanation for some long recognized skin patterns. Over time, descriptions became more precise as additional variants were reported in different families and patient groups. This history made CARD14 an important part of modern research on inherited inflammatory skin disease.